ZEGFROVY
NDC 84694-102, Sunvozertinib, tablet, film coated, from Dizal Pharmaceutical Co., Ltd..
- Product NDC
- 84694-102
- Status
- Listed
- Labeler
- Dizal Pharmaceutical Co., Ltd.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219839
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/84694-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SUNVOZERTINIB200 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 84694-102-01 | 84694010201 | 1 BOTTLE in 1 CARTON (84694-102-01) / 30 TABLET, FILM COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/349fa84e-1fdb-4976-b1bb-689b80eac8ad
Use it
Look up 84694-102 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/84694-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 84694-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.